Christopher Henney Explained

Christopher Henney (born 1941) is an American immunologist and biotechnology entrepreneur who co-founded Immunex Corp. and Icos Corporation, and led Dendreon Corp. to the development of the first FDA-approved cancer vaccination therapy.

Background

Henney was born in 1941 in Birmingham, England. He was educated at Prince Albert School, King Edward VI School Aston [1] and at the University of Birmingham, where he earned B.Sc 1962 Ph.D[1965] and was awarded D.Sc. for his contributions to the field of immunology in 1972.[2] [3] After postdoctoral studies at the University of Colorado School of Medicine and the Immunoglobulin Reference Centre in Lausanne Switzerland, he was appointed to the faculty of Johns Hopkins University Medical School[1972-1978],before taking the first chair of Basic Immunology at the Fred Hutchinson Cancer Center,Seattle in 1978.[4] [5] [6]

Henney,with Steven Gillis and Stephen Duzan co-founded Immunex Corporation in 1980 .Immunex developed Leukine, an agent for the stimulation of white blood cells after chemotherapy and bone marrow transplantation The company also developed Enbrel for autoimmune diseases and has proven a particularly important drug for the treatment of Rheumatoid Arthritis. Immunex was acquired by Amgen Inc in 2002, in what was, at the time,the financially most important sale in the biotechnology sector [7] [8] [9] [10] [11] [12] [13]

In 1989, Henney co-founded Icos Corporation with George Rathman, Amgen co-founder and CEO, and Genetic Systems founder Robert Nowinski .The company developed Cialis for erectile dysfunction and was acquired by Eli Lilly in 2007.[14] [15]

Henney led Dendreon Corp as CEO [1995-2003]and Chairman [1995-2005].Dendreon a cell-based therapy company developed Provenge for the treatment of prostate cancer,the first FDA-approved cancer vaccine therapy .[16] [17] [18] [19]

Over 40 year period Henney served as chairman for many publicly-held biotechnology companies including: Dendreon, Cyclacel Corp., Cascadian Therapeutics, SGX Pharmaceutics and Anthera Pharmaceuticals and on the board of many others including Immunex, Icos, and Prothena[20]

Awards and honors

In 2011, Henney was inducted into the Biotech Hall of Fame.[21]

In 2019, Henney was inducted into the Washington Life Science Hall of Fame.[22]

References

  1. Web site: Dr Chris Henney - Prince Albert School. 2021-02-14. www.princealbert.bham.sch.uk.
  2. Web site: Manchester United's Chief Exec and BBC Sport Boss Honoured by the University of Birmingham. 2021-02-14. University of Birmingham. en-GB.
  3. Web site: Christopher Henney News, Articles and Opinions. 2021-02-14. Xconomy. en.
  4. Henney. Christopher S.. Ishizaka. Kimishige. 1968-04-01. Antigenic Determinants Specific for Aggregated γG-Globulins. The Journal of Immunology. en. 100. 4. 718–725. 10.4049/jimmunol.100.4.718 . 0022-1767. 4171392. 255326650 . free.
  5. Web site: Immunological Unresponsiveness to Specific Antigenic Determinants in Human γ G Globulin. 2021-03-06. insights.ovid.com.
  6. Marie Daghlian. 2015-12-15. LSFMAGFALL2015-reduced.
  7. News: Deutsch. Claudia H.. 1988-11-06. AN INDUSTRY OF SCIENTISTS TURNS TO VETERAN MANAGERS (Published 1988). en-US. The New York Times. 2021-02-14. 0362-4331.
  8. News: Fisher. Lawrence M.. 1991-02-14. Talking Deals; Getting New Cash For Biotechnology (Published 1991). en-US. The New York Times. 2021-02-14. 0362-4331.
  9. Web site: Looking back at Immunex and ahead to Seattle's biotech future. live. https://web.archive.org/web/20111202010939/http://www.bizjournals.com:80/seattle/blog/2011/11/looking-back-at-immunex-and-forward-to.html . 2011-12-02 . 2021-02-14. www.bizjournals.com.
  10. Web site: LEFF. MARNI. 2001-12-15. Amgen-Immunex merger would unite like companies. 2021-02-14. seattlepi.com. en-US.
  11. Web site: Immunex' Enbrel Launched In USA For Arthritis - Pharmaceutical industr. 2021-03-26. www.thepharmaletter.com.
  12. Web site: FDA approves Novantrone for secondary progressive MS. live. 2021-03-26. www.pharmaceuticalonline.com. https://web.archive.org/web/20200731103907/https://www.pharmaceuticalonline.com/doc/fda-approves-novantrone-for-secondary-progres-0001 . 2020-07-31 .
  13. Web site: US Approves Immunex' Liquid Leukine - Pharmaceutical industry news. 2021-03-26. www.thepharmaletter.com.
  14. Web site: 18 October 2006. Icos sale a blow to local biotech. Seattle Times.
  15. Web site: Times. The Seattle. 2006-10-18. Eli Lilly to acquire Icos. 2021-03-14. Lewiston Sun Journal.
  16. Web site: 2002-02-21. BIOTECH LEADER PLEADS his sector's SPECIAL CASE. 2021-04-01. Australian Financial Review. en.
  17. Web site: Herper. Matthew. The Man Behind The First Cancer-Treating Vaccine On The FDA And Innovation. 2021-02-17. Forbes. en.
  18. Web site: Biotech firm moving here. live. 2021-02-17. www.bizjournals.com. https://web.archive.org/web/20030131224909/http://www.bizjournals.com:80/seattle/stories/1998/08/10/story2.html . 2003-01-31 .
  19. Web site: Herper. Matthew. CEO: Corporate Egghead Officer. 2021-03-31. Forbes. en.
  20. Web site: Booth. Bruce. Distinctive Corporate Culture In Biotech: Walk The Talk. live. 2021-04-01. Forbes. en. https://web.archive.org/web/20170725151341/https://www.forbes.com/sites/brucebooth/2017/07/25/distinctive-biotech-corporate-culture-walk-the-talk/ . 2017-07-25 .
  21. Web site: Chris Henney Receives 2011 Hall of Fame Award at Annual Biotech CEO Meeting at Laguna Beach. 2021-04-06. BioSpace. en-US.
  22. Web site: 2019-04-23. Life Science Washington Announces 2019 Inductees into the Washington Life Science Hall of Fame. 2021-04-06. AP NEWS.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Christopher Henney".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.